- Home
- ANGO
ANGO
AngioDynamics Inc.
as 02-21-2025 4:00pm EST
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
| Founded: | 1988 | Country: | United States |
| Employees: | N/A | City: | LATHAM |
| Market Cap: | 279.1M | IPO Year: | 2004 |
| Target Price: | $13.00 | AVG Volume (30 days): | 606.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -5.55 | EPS Growth: | N/A |
| 52 Week Low/High: | $5.26 - $13.50 | Next Earning Date: | 04-03-2025 |
| Revenue: | $286,498,000 | Revenue Growth: | -13.06% |
| Revenue Growth (this year): | -4.38% | Revenue Growth (next year): | 6.63% |
Stock Insider Trading Activity of AngioDynamics Inc. (ANGO)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Nighan Warren JR | ANGO | SVP Quality and Regulatory | Jan 16 '25 | Sell | $12.31 | 4,060 | $49,978.60 | 41,817 |
Latest AngioDynamics Inc. News
ANGO Breaking Stock News: Dive into ANGO Ticker-Specific Updates for Smart Investing
Zacks
15 days ago
AngioDynamics (ANGO) Down 14.2% Since Last Earnings Report: Can It Rebound?
Zacks
22 days ago
ANGO Stock Looks Promising on New Ischemia Study for Auryon System
Business Wire
23 days ago
AngioDynamics Initiates AMBITION BTK RCT and Registry to Advance Treatment for Critical Limb Ischemia
Simply Wall St.
a month ago
With 74% institutional ownership, AngioDynamics, Inc. (NASDAQ:ANGO) is a favorite amongst the big guns
Business Wire
a month ago
AngioDynamics Announces Publication of APEX-AV Trial Results in JSCAI
Zacks
a month ago
AngioDynamics Stock Up on Q2 Earnings Beat, Gross Margin Declines
TipRanks
a month ago
AngioDynamics Reports Growth and Advances NanoKnife System
GuruFocus.com
a month ago
AngioDynamics Inc (ANGO) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
Compare ANGO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ANGO AngioDynamics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.